Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The RNA-induced silencing complex/Argonaute-2 (RISC/Ago2) complex is a multi-protein ribonucleoprotein machinery that serves as the central effector of the RNA interference (RNAi) pathway. The complex is composed of the catalytic endonuclease Argonaute-2 (Ago2) bound to a single-stranded guide RNA, such as a microRNA or small interfering RNA. The guide RNA directs the RISC/Ago2 complex to complementary target messenger RNAs (mRNAs), leading to sequence-specific mRNA cleavage, translational repression, or mRNA degradation. This machinery plays a critical role in post-transcriptional gene regulation, cellular development, and host defense against viral infections.
In disease states, dysregulation of the RISC/Ago2 complex and its associated microRNAs is implicated in oncogenesis, viral replication (such as hepatitis B and C), and neurodevelopmental disorders. The complex is highly exploited therapeutically; synthetic double-stranded siRNA drugs (such as patisiran, inclisiran, and givosiran) are designed to load into the RISC/Ago2 complex to selectively silence disease-causing genes. Additionally, small-molecule inhibitors of Ago2 (such as BCI-137 and aurintricarboxylic acid) are being investigated to block RISC assembly or miRNA loading, offering potential therapeutic strategies for cancers and other conditions driven by aberrant miRNA activity.
Activation of the RNA interference pathway through loading of synthetic siRNA guide strands to execute sequence-specific target mRNA cleavage; or small-molecule inhibition of RISC assembly and miRNA/siRNA loading to block gene silencing.
12 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA-induced silencing complex/Argonaute-2 complex (RISC/Ago2 complex) (RISC/Ago2 complex).